Showing 1 - 7 results of 7 for search 'Jan Baptist Vermorken', query time: 0.50s Refine Results
  1. 1
    Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck

    Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck by Petr Szturz, Petr Szturz, Jan Baptist Vermorken, Jan Baptist Vermorken

    Published 2016-08-01
    Get full text
    Article
  2. 2
    Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma

    Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma by Kai-Bin Yang, Kai-Bin Yang, Cheng Xu, Yu-Pei Chen, Jan Baptist Vermorken, Jan Baptist Vermorken, Brian O'Sullivan, Jun Ma

    Published 2021-03-01
    Get full text
    Article
  3. 3
    The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy

    The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy by Hannah Zaryouh, Ines De Pauw, Hasan Baysal, Patrick Pauwels, Patrick Pauwels, Marc Peeters, Marc Peeters, Jan Baptist Vermorken, Jan Baptist Vermorken, Filip Lardon, An Wouters

    Published 2021-09-01
    Get full text
    Article
  4. 4
    Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?

    Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy? by Hannah Zaryouh, Jinthe Van Loenhout, Marc Peeters, Jan Baptist Vermorken, Filip Lardon, An Wouters

    Published 2022-12-01
    Get full text
    Article
  5. 5
    Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib

    Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib by Ines De Pauw, Filip Lardon, Jolien Van den Bossche, Hasan Baysal, Patrick Pauwels, Marc Peeters, Jan Baptist Vermorken, An Wouters

    Published 2019-01-01
    Get full text
    Article
  6. 6
    The prognostic impact of the immune signature in head and neck squamous cell carcinoma

    The prognostic impact of the immune signature in head and neck squamous cell carcinoma by Hasan Baysal, Vasiliki Siozopoulou, Vasiliki Siozopoulou, Hannah Zaryouh, Christophe Hermans, Ho Wa Lau, Hilde Lambrechts, Erik Fransen, Ines De Pauw, Julie Jacobs, Marc Peeters, Marc Peeters, Patrick Pauwels, Patrick Pauwels, Jan Baptist Vermorken, Jan Baptist Vermorken, Evelien Smits, Evelien Smits, Filip Lardon, Jorrit De Waele, An Wouters

    Published 2022-10-01
    Get full text
    Article
  7. 7
    Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines

    Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines by Ines De Pauw, Filip Lardon, Jolien Van den Bossche, Hasan Baysal, Erik Fransen, Vanessa Deschoolmeester, Patrick Pauwels, Marc Peeters, Jan Baptist Vermorken, An Wouters

    Published 2018-06-01
    Get full text
    Article

Search Tools: